Required	Nordling, C. O. “A New Theory on Cancer-Inducing Mechanism.” Br J Cancer 7, no. 1 (Mar 1953): 68-72.
Required	Nordling, C. O. “Theories and statistics of cancer.” Nord Med. 47, no. 24 (Jun 13, 1952): 817-20.
Required	**Armitage, P., and R. Doll. “The Age Distribution of Cancer and a Multi-Stage Theory of Carcinogenesis.” Br J Cancer 8, no. 1 (Mar 1954): 1-12.
Required	**Armitage, P., and R. Doll. “A Two-Stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer.” Br J Cancer 11, no. 2 (Jun 1957): 161-9.
Required	**Armitage, P., and R. Doll. “The Age Distribution of Cancer and a Multi-Stage Theory of Carcinogenesis.” Br J Cancer 91, no. 12 (Dec 13, 2004A): 1983-9.
Required	**Armitage, P., and R. Doll. “The Age distribution of Cancer and a Multi-Stage Theory of Carcinogenosis.” Int J Epidemiol 33, no. 6 (Dec 2004B): 1174-9. Epub Aug 19, 2004.
Required	Moolgavkar, S. H., and A. G. Knudson, Jr. “Mutation and Cancer: A Model for Human Carcinogenesis.” J Natl Cancer Inst 66, no. 6 (Jun 1981): 1037-52.
Required	**Stein, W.D. “Analysis of cancer incidence data on the basis of multistage and clonal growth models.” Adv. Cancer Res. 56 (1991): 161-213.
Required	**Herrero-Jimenez, P., G. Thilly, P. J. Southam, A. Tomita-Mitchell, S. Morgenthaler, E. E. Furth, and W. G. Thilly. “Mutation, Cell Kinetics, and Subpopulations at Risk for Colon Cancer in the United States.” Mutat Res 400, nos. 1-2 (May 25, 1998): 553-78.
Required	**Herrero-Jimenez, P., A. Tomita-Mitchell, E. E. Furth, S. Morgenthaler, and W. G. Thilly. “Population Risk and Physiological Rate Parameters for Colon Cancer. The Union of an Explicit Model for Carcinogenesis with the Public Health Records of the United States.” Mutat Res 447, no. 1 (Jan 17, 2000): 73-116.
Required	Morgenthaler, S., P. Herrero, and W. G. Thilly. “Multistage Carcinogenesis and the Fraction at Risk.” J Math Biol 49, no. 5 (Nov 2004): 455-67.
Required	Morgenthaler, S., P. Herrero, and W. G. Thilly. “Multistage Carcinogenesis and the Fraction at Risk.” J Math Biol 49, no. 5 (Nov 2004): 455-67.
Required	Hemminki, K., and B. Chen. “Familial Risk for Colorectal Cancers Are Mainly Due to Heritable Causes Cancer Epidemiology.” Biomarkers and Prevention 13 (2004A): 1253-1256.
Required	Hemminki, K., and B. Chen. “Familial Association of Colorectal Adenocarcinoma With Cancers at Other Sites.” Eur J Cancer 40, no. 16 (Nov 2004B): 2480-7.
Required	Hemminki, K., and K. Czene. “Attributable Risks of Familial Cancer from the Family-Cancer Database.” Cancer Epidemiol Biomarkers Prev 11, no. 12 (Dec 2002): 1638-44.
Required	Hemminki, K., and X. Li. “Familial and Second Primary Pancreatic Cancers: A Nationwide Epidemiologic Study from Sweden.” Int J Cancer 103, no. 4 (Feb 10, 2003): 525-30.
Required	Hemminki, K., and X. Li. “Related Familial colorectal denocarcinoma from the Swedish Family-Cancer Database.” Int J Cancer 94, no. 5 (Dec 1, 2001A): 743-8.
Required	Hemminki, K., and X. Li. “Related Familial colorectal denocarcinoma from the Swedish Family-Cancer Database.” Int J Cancer 94, no. 5 (Dec 1, 2001A): 743-8.
Required	Hemminki, K., and X. Li. “Increased Cancer Risk in the Offspring of Women with Colorectal Carcinoma. A Swedish Register-Based Cohort Study.” Cancer  91, no. 5 (Mar 1, 2001B): 1061-3.
Required	**Hemminki, K., I. Lonnstedt, P. Vaittinen, and P. Lichtenstein. “Estimation of Genetic and Environmental Components in Colorectal and Lung Cancer and Melanoma.” Genet Epidemiol 20, no. 1 (Jan 2001): 107-116.
Required	**Lichtenstein, P., N. V. Holm, P. K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki. “Environmental and Heritable Factors in the Causation of Cancer - Analyses of Cohorts of Twins from Sweden, Denmark, and Finland.” N Engl J Med 343, no. 2 (Jul 13, 2000): 78-85.
Required	Calvari-Sforza, L. L., and W. F. Bodmer. The Genetics of Human Populations. San Francisco: W. H. Freeman, 1971.
Required	Calvari-Sforza, L. L., P. Menozzi, and A. Piazza. The History and Geography of Human Genes. Princeton: Princeton University Press, 1994.
Required	Hartl, D. L. A Primer of  Population Genetics. 3rd ed. Sunderland, MA: Sinauer, 2000.
Required	Vogel, F., and R. Rathenberg. “Spontaneous Mutation in Man.” Adv Hum Genet 5 (1975): 223-318.
Required	Lander, E. S., and D. Botstein. “Mapping Complex Genetic Traits in Humans: New Methods Using a Complete RFLP Linkage Map.” Cold Spring Harb Symp Quant Biol 51, Part 1 (1986): 49-62.
Required	Lander, E. S., and D. Botstein. “Mapping Mendelian Factors Underlying Quantitative Traits Using RFLP Linkage Maps.” Genetics 121, no. 1 (Jan 1989): 185-99. [Erratum in: Genetics 136, no. 2 (Feb 1994): 705.]
Required	**Tomita-Mitchell, A., B. P. Muniappan, P. Herrero-Jimenez, H. Zarbl, and W. G. Thilly. “Single Nucleotide Polymorphism Spectra in Newborns and Centenarians: Identification of Genes Coding for Risk of Mortal Disease.” Gene 223, no. 1-2 (Nov 26, 1998): 381-91.
Required	Li-Sucholeiki, X. C., and W. G. Thilly. “A Sensitive Scanning Technology for Low Frequency Nuclear Point Mutations in Human Genomic DNA.” Nucleic Acids Res 28, no. 9 (May 1, 2000): E44.
Required	**Hirschhorn, J. N., K. Lohmueller, E. Byrne, and K. Hirschhorn. “A Comprehensive Review of Genetic Association Studies.” Genet Med 4, no. 2 (Mar-Apr 2002): 45-61.
Required	Nunney, L. “The Population Genetics of Multistage Carcinogenesis.” Proc R Soc Lond B Biol Sci 270, no. 1520 (Jun 7, 2003): 1183-91.
Required	**Morgenthaler, S., and W. G. Thilly. Pangenomic Search for Genetic Risks for Common Diseases, 2005. (Manuscript in preparation.)
Required	Scientific American, September 1996.
Required	**Wynder, E. L., E. A. Graham. “Tobacco Smoking as a Possible Etiologic Factor in Bronchiogenic Carcinoma; A Study of 684 Proved Cases.” J Am Med Assoc 143, no. 4 (May 27, 1950): 329-36.
Required	Armitage, P., et al. “Dose-Response Relationship in Radiation Leukaemia.” Nature 184, Supplement 21 (Nov 21, 1959): 1669-70.
Required	**Thilly, W. G. “Have Environmental Mutagens Caused Oncomutations in People?” Nature Genetics 34 (2003): 255-259.
Required	Wogan, G. N.,  S. S. Hecht, J. S. Felton, A. H. Conney, and L. A. Loeb. “Environmental and Chemical Carcinogenesis.” Semin Cancer Biol 14, no. 6 (Dec 2004): 473-86.
Required	Chan, A .T., E. L. Giovannucci, E. S. Schernhammer, G. A. Colditz, D. J. Hunter, W. C. Willett, and C. S. Fuchs. “A Prospective Study of Aspirin use and the Risk for Colorectal Adenoma.” Ann Intern Med 140, no. 3 (Feb 3, 2004): 157-66.
Required	**Trichopoulos, D., F. P. Li, and D. J. Hunter. “What Causes Cancer?” Sci Am 275, no. 3 (Sep 1996): 80-7.
Required	Harris, D. M., and V. L. Go. “Vitamin D and Colon Carcinogenesis.” J Nutr 134, no. 12 Supplement (Dec 2004): 3463S-3471S.
Required	Whelan, J., and M. F. McEntee. “Dietary (n-6) PUFA and Intestinal Tumorigenesis.” J Nutr 134, no. 12 Supplement (Dec 2004): 3421S-3426S.
Required	Hung, H. C., K. J. Joshipura, R. Jiang, F. B. Hu, D. Hunter, S. A. Smith-Warner, G. A. Colditz, B. Rosner, D. Spiegelman, and W. C. Willett. “Fruit and Vegetable Intake and Risk of Major Chronic Disease.” J Natl Cancer Inst 96, no. 21 (Nov 3, 2004): 1577-84.
Required	Cohnheim, J. “Ueber Entzundung und Eiterung.” Path Anat Physiol Klin Med 40 (1867): 1-79.
Required	**Sell, S. “Stem Cell Origin of Cancer and Differentiation Therapy.” Crit Rev Oncol Hematol 51, no. 1 (Jul 2004): 1-28.
Required	**Gostjeva, E. V., L. Zukerberg, D. Chung, and W. G. Thilly. Nuclear Morphotypes and Metamorphoses in Human Colonic Ontogenesis and Carcinogenesis. (2005) Manuscript submitted.
Required	Boveri, T. Zur Frage der Entstehung maligner Tumoren. Fischer, Jena, 1914.
Required	Boveri, T. “The origin of malignant tumors.” Baltimore: Williams Wilkins, 1929.
Required	**Balmain, A. “Cancer Genetics: From Boveri and Mendel to Microarrays.” Nat Rev Cancer 1 (2001): 77-82.
Required	Temin, H. M. “The Protovirus Hypothesis: Speculations on the Significance of RNA-Directed DNA Synthesis for Normal Development and for Carcinogenesis.” J Natl Cancer Inst 46, no. 2 (Feb 1971): 3-7.
Required	Mitelman, F., B. Johansson, and F. Mertens. Catalog of Chromosome Aberrations in Cancer. 5th ed. CD-ROM version with annual updates. New York: Wiley, 1998.
Required	Anonymous. Mitelman Database of Chromosome Aberrations in Cancer. Edited by F. Mitelman, B. Johansson, F. Mertens. 2002.
Required	Knudson, A. G., Jr. “Mutation and Cancer: Statistical Study of Retinoblastoma.” Proc Natl Acad Sci U S A 68, no. 4 (Apr 1971): 820-3.
Required	Groden, J.,  A. Thliveris, W. Samowitz, M. Carlson, L. Gelbert, H. Albertsen, G. Joslyn, J. Stevens, L. Spirio, and M. Robertson, et al. “Identification and Characterization of the Familial Adenomatous Polyposis Coli Gene.” Cell. 66, no. 3 (Aug 9, 1991): 589-600.
Required	**Knudson, A. G. “Cancer Genetics.” Am J Med Genet 111, no. 1 (Jul 22, 2002): 96-102.
Required	Weinberg, R. A. “How Cancer Arises.” Sci Am 275, no. 3 (Sep 1996): 62-70.
Required	**Rangarajan, A., S. J. Hong, A. Gifford, and R. A. Weinberg. “Species- and Cell Type-specific Requirements for Cellular Transformation.” Cancer Cell 6, no. 2 (Aug 2004): 171-83.
Required	Keohavong, P., and W. G. Thilly. “Fidelity of DNA Polymerases in DNA Amplification.” Proc Natl Acad Sci U S A 86, no. 23 (Dec 1989): 9253-7.
Required	**Loeb, L. A., and K. C. Cheng. “Errors in DNA Synthesis: A Source of Spontaneous Mutations.” Mutat Res 238, no. 3 (May 1990): 297-304.
Required	**Khrapko, K., H. A. Coller, P. C. Andre, X. C. Li, J. S. Hanekamp, and W. G. Thilly. “Mitochondrial Mutational Spectra in Human Cells and Tissues.” Proc Natl Acad Sci U S A 94, no. 25 (Dec 9, 1997A): 13798-803.
Required	**Coller, H. A., K. Khrapko, A. Torres, M. W. Frampton, M. J. Utell, and W. G. Thilly. “Mutational Spectra of a 100-base Pair Mitochondrial DNA Target Sequence in Bronchial Epithelial Cells: A Comparison of Smoking and Nonsmoking Twins.” Cancer Res 58, no. 6 (Mar 15, 1998): 1268-77.
Required	**Muniappan, B. P., and W. G. Thilly. “The DNA Polymerase Beta Replication Error Spectrum in the Adenomatous Polyposis Coli Gene contains Human Colon Tumor Mutational Hotspots.” Cancer Res 62, no. 11 (Jun 1, 2002): 3271-5.
Required	Coller, H. A., K. Khrapko, N. D. Bodyak, E. Nekhaeva, P. Herrero-Jimenez, and W. G. Thilly. “High Frequency of Homoplasmic Mitochondrial DNA Mutations in Human Tumors can be Explained Without Selection.” Nat Genet 28, no. 2 (Jun 2001): 147-50.
Required	Zheng, W. M., K. Khrapko, H. Coller, W. G. Thilly, and W. Copeland. The Gamma DNA Polymerase Replication Error Spectrum Contains Human Tissue Mitochondrial Hotspots. (Manuscript draft, 2005)
Required	Wogan, G. N., S. S. Hecht, J. S. Felton, A. H. Conney, and L. A. Loeb. “Environmental and Chemical Carcinogenesis.” Semin Cancer Biol 14, no. 6 (Dec 2004): 473-86.
Required	Tomita-Mitchell, A., L. L. Ling, C. L. Glover, J. Goodluck-Griffith, and W. G. Thilly. “The Mutational Spectrum of the HPRT Gene from Human T Cells in Vivo Shares a Significant Concordant Set of Hot Spots with MNNG-treated Human Cells.” Cancer Res 63, no. 18 (Sep 15, 2003): 5793-8.
Required	Thilly, W. G. “Have Environmental Mutagens Caused Onco Mutations in People?” Nature Genetics 34 (2003): 255-259.
Required	**Benzer, S. “The Fine Structure of the Gene.” Sci Am 206 (Jan 1962): 70-84.
Required	Nomura, M., and S. Benzer. “The Nature of the “Deletion” Mutants in the rII Region of Phage T4.” J Mol Biol 3 (Oct 1961): 684-92.
Required	Benzer, S. “Genetic Fine Structure.” Harvey Lect 56 (1960-1961): 1-21.
Required	Brenner, S., S. Benzer, and L. Barnett. “Distribution of Proflavin-induced Mutations in the Genetic Fine Structure.” Nature 182, no. 4641 (Oct 11, 1958): 983-5.
Required	Benzer, S. “Genetic Fine Structure and its Relation to the DNA Molecule.” Brookhaven Symp Biol 8 (Feb 1956): 3-5.
Required	Khrapko, K., P. Andre, R. Cha, G. Hu, and W. G. Thilly. “Mutational Spectrometry: Means and Ends.” Prog Nucleic Acid Res Mol Biol 49 (1994A): 285-312.
Required	Khrapko, K., J. S. Hanekamp, W. G. Thilly, A. Belenkii, F. Foret, and B. L. Karger. “Constant Denaturant Capillary Electrophoresis (CDCE): A High Resolution Approach to Mutational Analysis.” Nucleic Acids Res 22, no. 3 (Feb 11, 1994B): 364-9.
Required	Khrapko, K., H. Coller, P. Andre, X. C. Li, F. Foret, A. Belenky, B. L. Karger, and W. G. Thilly. “Mutational Spectrometry Without Phenotypic Selection: Human Mitochondrial DNA.” Nucleic Acids Res 25, no. 4 (Feb 15, 1997B): 685-93.
Required	Andre, P., A. Kim, K. Khrapko, and W. G. Thilly. “Fidelity and Mutational Spectrum of Pfu DNA Polymerase on a Human Mitochondrial DNA Sequence.” Genome Res 7, no. 8 (Aug 1997): 843-52.
Required	Khrapko, K., H. A. Coller, X. C. Li-Sucholeiki, P. C. Andre, and W. G. Thilly. “High Resolution Analysis of Point Mutations by Constant Denaturant Capillary Electrophoresis (CDCE).” Methods Mol Biol 163 (2001): 57-72.
Required	Ekstrom, P. O., J. Bjorheim, G. Gaudernack, and K. E. Giercksky. “Population Screening of Single-nucleotide Polymorphisms Exemplified by Analysis of 8000 Alleles.” J Biomol Screen 7, no. 6 (Dec 2002): 501-6.
Required	Minarik, M., L. Minarikova, J. Bjorheim, and P. O. Ekstrom. “Cycling Gradient Capillary Electrophoresis: A Low-cost Tool for High-throughput Analysis of Genetic Variations.” Electrophoresis 24, no. 11 (Jun 2003): 1716-22.
Required	**Bjorheim, J., T. W. Abrahamsen, A. T. Kristensen, G. Gaudernack, and P. O. Ekstrom. “Approach to Analysis of Single Nucleotide Polymorphisms by Automated Constant Denaturant Capillary Electrophoresis.” Mutat Res 526, no. 1-2 (May 15, 2003): 75-83.
Required	Luria, S. E. “Mutation of Bacterial Viruses Affecting their Host Range.” Genetics 30 (1945): 84-99.
Required	Leung, E. S. “A Modified Method for the 1000-compartment Fluctuation Test.” Heredity 33, no. 3 (Dec 1974): 417-9.
